DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid Tumors

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid Tumors	Advanced or Metastatic Solid Tumors	Recruiting	Phase 1	2025-06-26		NCT05785754

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
DynamiCure Biotechnology	2

35 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Asan Medical Center	Seoul	South Korea	131
Cabrini Hospital	Malvern	Australia	12
Cha University Bundang Medical Center	Gyeonggi-do	South Korea	1
Dana Farber Cancer Institute	Boston	United States	300
Dong-A University Hospital	Busan	South Korea	42
HonorHealth	Scottsdale	United States	21
Inje University Haeundae Paik Hospital	Busan	South Korea	48
John Hopkins Sidney Kimmel Comprehensive Cancer Center	Baltimore	United States	2
Kaohsiung Medical University Chung-Ho Memorial Hospital	Kaohsiung City	Taiwan	77
Linear Clinical Research Limited	Nedlands	Australia	8
Liverpool Hospital	Liverpool	Australia	1
Mater Misericordiae Health Services Brisbane Ltd	South Brisbane	Australia	1
Mayo Clinic	Rochester	United States	664
Mayo Clinic	Phoenix	United States	50
Mayo Clinic	Jacksonville	United States	122
Monash Health	Clayton	Australia	74
Montefiore	The Bronx	United States	4
National Cheng Kung University Hospital	Tainan	Taiwan	135
National Taiwan University Hospital	Taipei	Taiwan	203
Ohio State University	Columbus	United States	169
Sarah Cannon Research Institute Denver Healthone	Denver	United States	1
Scientia Clinical Research	Randwick	Australia	20
Scri Oncology Partners	Nashville	United States	156
Severance Hospital, Yonsei University Health System	Seoul	South Korea	134
Southern Oncology Clinical Research Unit (SOCRU)	Bedford Park	Australia	4

Clinical trials